Your browser doesn't support javascript.
loading
A Phase 2 Trial of Guselkumab versus Adalimumab for Plaque Psoriasis.
Gordon, Kenneth B; Duffin, Kristina Callis; Bissonnette, Robert; Prinz, Jörg C; Wasfi, Yasmine; Li, Shu; Shen, Yaung-Kaung; Szapary, Philippe; Randazzo, Bruce; Reich, Kristian.
Afiliação
  • Gordon KB; From the Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago (K.B.G.); the Department of Dermatology, University of Utah School of Medicine, Salt Lake City (K.C.D.); Innovaderm Research, Montreal (R.B.); the Department of Dermatology, Ludwig-Maximilians-Universität München, Munich (J.C.P.), and the Dermatologikum Hamburg, Hamburg (K.R.) - both in Germany; and Janssen Research and Development, Spring House (Y.W., S.L., Y.-K.S., P.S., B.R.), and the Department
N Engl J Med ; 373(2): 136-44, 2015 Jul 09.
Article em En | MEDLINE | ID: mdl-26154787

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Psoríase / Fator de Necrose Tumoral alfa / Interleucina-23 / Anticorpos Monoclonais Humanizados / Anti-Inflamatórios / Anticorpos Monoclonais Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: N Engl J Med Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Psoríase / Fator de Necrose Tumoral alfa / Interleucina-23 / Anticorpos Monoclonais Humanizados / Anti-Inflamatórios / Anticorpos Monoclonais Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: N Engl J Med Ano de publicação: 2015 Tipo de documento: Article